JPH07308184A - Device for simply detecting resistant microorganism - Google Patents

Device for simply detecting resistant microorganism

Info

Publication number
JPH07308184A
JPH07308184A JP12574094A JP12574094A JPH07308184A JP H07308184 A JPH07308184 A JP H07308184A JP 12574094 A JP12574094 A JP 12574094A JP 12574094 A JP12574094 A JP 12574094A JP H07308184 A JPH07308184 A JP H07308184A
Authority
JP
Japan
Prior art keywords
medium
microorganism
antibiotic
lower tube
resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP12574094A
Other languages
Japanese (ja)
Inventor
Naomi Osawa
尚美 大澤
Hiroyuki Ishisone
博之 石曽根
Atsushi Miwa
亜通志 三和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERUTETSUKU LAB KK
Nihon Millipore KK
Original Assignee
SERUTETSUKU LAB KK
Nihon Millipore KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERUTETSUKU LAB KK, Nihon Millipore KK filed Critical SERUTETSUKU LAB KK
Priority to JP12574094A priority Critical patent/JPH07308184A/en
Publication of JPH07308184A publication Critical patent/JPH07308184A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C12M41/36Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of biomass, e.g. colony counters or by turbidity measurements
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/34Internal compartments or partitions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/38Caps; Covers; Plugs; Pouring means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/02Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by impregnation, e.g. using swabs or loops
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/08Flask, bottle or test tube

Abstract

PURPOSE:To provide the subject device for readily detecting a microorganism resistant to many agents, comprising microorganism collecting ends to be mutually brought into contact with each other in an integrated way by action of external force, containing an antibiotic and a medium, arranging the antibiotic and the medium in a non-contact way in a container and having long-term shelf stability. CONSTITUTION:In a device for detecting a microorganism by culturing a microorganism in a medium and observing change of the medium, the device consists of a transparent lower tube 1 having an open top and a closed bottom and an upper tube 2 which has a closed top, a lower end closed with a porous plate 3, is used also as a cap to be hermetically engaged with the lower tube 1 and to seal the lower tube 1 and is provided with a glass ampule 4 having sealed the medium between the top and the porous plate 3 at the bottom. The porous plate 3 is provided with an applicator 6 for collecting a microorganism, having the other end extending in the lower tube 1 and a disc chip 5 impregnated with the antibiotic to suppress growth of microorganisms except the resistant microorganism. After a cell is collected by the applicator 6, the glass ampule 2 is broken, the medium is guided to the lower tube 1 and the microorganism is cultured to detect the microorganism by change of the medium.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、長期保存性にすぐれ、
操作が簡単で、携帯し易い耐性菌、特にメチシリン耐性
黄色ブドウ球菌(Methicillin−resistant Staphylococ
cus aureus;以下、MRSAと略記)などの検知装置に係わ
る。
The present invention has excellent long-term storage stability,
Easy-to-use and easy-to-carry resistant bacteria, especially methicillin-resistant Staphylococcus
cus aureus; hereinafter abbreviated as MRSA).

【0002】[0002]

【従来の技術】近年の医療の高度化、治療の進歩によ
り、抗菌薬、免疫抑制薬などが治療手段として広汎に使
用され、その恩恵を受けている。しかしながらその反
面、二次的現象として多くの耐性菌が産出されているこ
とも否めず、難治感染症の原因の一つとなっているMRSA
群はその代表的なものであり、医療上大きな問題となっ
ている。特に重症患者を治療する集中治療室内での感
染、老人ホームなどにおける抵抗力の弱った人への感染
は、腸炎や肺炎を惹き起こし、有効な薬物治療法がない
ため肺血症で死亡する例が増えている。
2. Description of the Related Art With the recent advances in medical treatment and advances in medical treatment, antibacterial drugs, immunosuppressive drugs and the like have been widely used as therapeutic means, and have benefited from them. However, on the other hand, it is undeniable that many resistant bacteria have been produced as a secondary phenomenon, which is one of the causes of intractable infections.
The group is the representative one, and it is a big medical problem. In particular, infection in an intensive care unit that treats critically ill patients, or infection of people with weak resistance in nursing homes, etc. causes enteritis and pneumonia, and there is no effective drug treatment method, resulting in death from lung disease. Is increasing.

【0003】また、これらMRSAだけでなく、多剤耐性コ
アグラーゼ陰性ブドウ球菌(Coagulase negative Staph
ylococcus)(以下、多剤耐性CNSと略記)などが医療従事
者からも多く検知され、年々増加する傾向にある。
Not only these MRSAs but also multidrug-resistant coagulase negative Staph
ylococcus) (hereinafter abbreviated as multidrug-resistant CNS) is often detected by medical staff and tends to increase year by year.

【0004】これに対し、MRSAや多剤耐性CNS感染症を
増やさないためには、感染の早期発見を行い、的確な防
止対策をとることが重要と考えられる。特に、この感染
の早期発見に当たっては、早く、簡単に、確実に、かつ
安価に、より多くの検体をスクリーニングできることが
強く望まれてきている。
On the other hand, in order not to increase MRSA and multidrug-resistant CNS infections, it is considered important to detect infections early and take appropriate preventive measures. In particular, in early detection of this infection, it has been strongly desired to be able to screen more samples quickly, easily, reliably and inexpensively.

【0005】従来の技術は、患者検体や医療環境から採
取した検体を耐性菌用の選択培地を用いた寒天平板培地
上で培養し、培地上に形成されたコロニーを目視観察す
ると共に、その他の検知確認手段を用いて耐性菌を確
認、検知する方法が採用されており、例えば、吉田繁ら
は「迅速かつ簡便なメチシリン耐性黄色ブドウ球菌(MR
SA)検知用寒天平板の開発」を臨床病理(41巻 9号
p.1037〜1042(1993))に発表し、さらに最近では、
ポリメラーゼ連鎖反応(以下PCRと略記)を用いたMRSA
の判定方法が提案され、適用されてきている。
In the conventional technique, a patient sample or a sample collected from a medical environment is cultured on an agar plate medium using a selective medium for resistant bacteria, and the colonies formed on the medium are visually observed, and other A method of confirming and detecting a resistant bacterium using a detection confirmation means has been adopted. For example, Yoshida Shigeru et al. "Prompt and simple methicillin-resistant Staphylococcus aureus (MR
SA) Development of agar plate for detection ”in Clinical Pathology (Vol. 41 No. 9)
p. 1037-1042 (1993)), and more recently,
MRSA using polymerase chain reaction (hereinafter abbreviated as PCR)
Has been proposed and applied.

【0006】[0006]

【発明が解決しようとする課題】しかしながら、上述の
従来の方法は、いずれも操作上煩雑であること;寒天培
地上に生育したコロニーを判定するため、検知に当たり
専門技術又は熟練が必要であること;使用する生の培地
においては抗生物質の活性低下が避けられず、長期保存
ができないこと;検知費用が高いことなどの欠点を有
し、さらにPCRを用いた方法では、例えばMRSAの耐性遺
伝子mecA遺伝子を増幅することが考えられても、MRSA以
外にもmecA遺伝子を含有するブドウ球菌が存在すること
による精度の問題を有する上に、現状では大学付属病院
など一部で実施されているにすぎない。また特に菌検知
に簡便好適な装置として、特開昭62−171671号には、液
体培地をカプセルに収容し、さらに菌採取用のタンポン
と共に該カプセルを容器内に収容した装置が提案されて
いるが、添加された抗生物質は液体培地においても経時
的に活性を失い、耐性菌を選択的に検知するには信頼性
が乏しいことは否めない。
However, all of the above-mentioned conventional methods are complicated in operation; specialized techniques or skills are required for detection in order to determine colonies grown on an agar medium. In the raw medium to be used, a decrease in antibiotic activity is unavoidable and long-term storage is not possible; it has drawbacks such as high detection costs. Furthermore, in the method using PCR, for example, the MRSA resistance gene mecA Although it may be possible to amplify the gene, there is a problem of accuracy due to the presence of staphylococci containing the mecA gene in addition to MRSA, and at present it is only implemented in some hospitals such as university hospitals. Absent. Further, as a simple and particularly suitable device for detecting bacteria, JP-A-62-171671 proposes a device in which a liquid medium is contained in a capsule, and the capsule is also contained in a container together with a tampon for collecting bacteria. However, it cannot be denied that the added antibiotic loses its activity over time even in a liquid medium, and is not reliable enough to selectively detect resistant bacteria.

【0007】[0007]

【課題を解決するための手段】これらの事情に鑑み、鋭
意研究の結果、長期保存性に優れた携帯し易い選択的耐
性菌検知装置を開発し、これを使用することにより、専
門技術を必要とせず、24〜48時間内に耐性菌、例えばMR
SAや多剤耐性CNSの検知を行い得ることを見い出し、本
発明を完成するに至った。
[Means for Solving the Problems] In view of these circumstances, as a result of earnest research, a selective resistance bacterium detection device which is excellent in long-term storability and is easy to carry has been developed. And within 24 to 48 hours, resistant bacteria such as MR
The inventors have found that SA and multidrug resistant CNS can be detected, and completed the present invention.

【0008】即ち、菌を培地で培養して培地の変化を観
察することにより菌を検知する装置において、菌採取
端、抗生物質及び培地を包含してなり、使用前(すなわ
ち培養前)には少なくとも前記抗生物質と培地とが非接
触的に、菌採取に続く培養時には、外力を作用させて前
記菌採取端、抗生物質及び培地を一体的に接触させるよ
うに収容容器に配置されていることを特徴とする選択的
耐性菌検知装置を開発し、本発明に至った。
That is, in a device for detecting a bacterium by culturing the bacterium in a medium and observing a change in the medium, the bacterium is collected at the collecting end, antibiotics and medium, and before use (that is, before culturing). At least the non-contact of the antibiotic and the culture medium, when culturing subsequent to the bacteria collection, it is arranged in the container so that the bacteria collection end, the antibiotic and the culture medium are brought into contact with each other by applying an external force. The present invention has been accomplished by developing a selective resistant bacteria detection device characterized by:

【0009】ここに、菌採取端とは綿棒構造で代表され
るが、採取対象が液状を呈する場合には少なくとも部分
的にゴムやエラスティック性あるいは可撓性を有する材
料からなるパイプ状のスポイト機能を持つものや、先端
が種々の形のスパチュラ構造でもよく、要するに菌の採
取に好適な形状で無菌の収容容器に無菌状態で収容可能
であり、かつ菌採取後に培地と十分に接触し得る構造で
ある限り、あらゆる構造を採用し得る。また、菌採取端
は後述する抗生物質や培地とは使用前に接触しない状態
で収容されることが好ましいが、抗生物質とは若干の接
触があっても構わない。
Here, the bacteria collecting end is represented by a cotton swab structure, but when the object to be collected is liquid, a pipe-shaped dropper at least partially made of rubber or an elastic or flexible material. It may have a function or a spatula structure with various tips at the tip, in short, it can be stored aseptically in a sterile container with a shape suitable for collecting bacteria, and it can sufficiently contact with the medium after collecting bacteria. Any structure can be adopted as long as it is a structure. Further, it is preferable that the bacteria collection end is accommodated in a state in which it does not come into contact with an antibiotic or a medium described later before use, but there may be some contact with the antibiotic.

【0010】抗生物質は検知対象である耐性菌との関係
から種類が選定され、特に培地量との関係から適量が決
定される。抗生物質を予め培地に添加すると装置はより
コンパクトになるが、残念ながら先に述べた通り、抗生
物質の活性が経時的に低下することが多く、長期保存可
能な耐性菌の選択的検知装置にあっては、これら抗生物
質と培地とを非接触的に収容することが不可避と言え
る。収容形態としては直接容器内に粉末状で収容するこ
とも可能だが、水その他の適切な溶媒に溶解せしめ、適
量を担体(例えば濾紙等)に含浸し、凍結乾燥してディ
スクチップの形で収容するほか、収容容器内の好ましく
は培養する空間(以下培養部と呼称する)となるべき部
位にこの溶液を添加し、減圧乾燥等の方法でコ−ティン
グして収容するとか、あるいは又これら粉末や溶液を破
壊可能なアンプルやカプセルに充填して収容しても構わ
ない。収容容器内のいずれの部位に収容されてあって
も、培養前に容器を振るとか、液体培地で洗い流すとか
により培地と接触可能な状態での収容であれば、培養前
に培地と非接触状態を保つ限り如何なる収容方法を採用
しても構わない。
The type of the antibiotic is selected in relation to the resistant bacterium to be detected, and an appropriate amount is determined particularly in relation to the amount of medium. Although the device becomes more compact when antibiotics are added to the medium in advance, unfortunately, as mentioned above, the activity of antibiotics often decreases over time, making it a selective detection device for resistant bacteria that can be stored for a long period of time. In that case, it can be said that it is inevitable to accommodate these antibiotics and the medium in a non-contact manner. As a storage form, it can be stored directly in a container in powder form, but it is stored in the form of a disk chip by dissolving it in water or another suitable solvent, impregnating an appropriate amount into a carrier (for example, filter paper, etc.), freeze-drying. In addition, the solution is preferably added to a part of the container, which is to be a space for culture (hereinafter referred to as a culture part), and coated by a method such as vacuum drying to house the powder, or the powder thereof. Alternatively, the solution may be filled in a destructible ampoule or capsule to be stored. Regardless of where it is stored in the storage container, if it is stored in a state in which it can be contacted with the medium by shaking the container before culturing or rinsing with a liquid medium, it is in a non-contact state with the medium before culturing. Any storage method may be adopted as long as the above condition is maintained.

【0011】培地としては検知しようとする耐性菌に対
して公知の培地あるいはその改良培地を使用できる。培
地は好ましくは液体状態であり、アンプルもしくはカプ
セルに充填、収容されることが望ましいが、これに限定
されるものではなく、例えば壊れ易い隔壁により前記抗
生物質と接触しないように収容された寒天培地でもよ
く、この場合、培養時壊れ易い隔壁を該隔壁上に載置さ
れているガラスでコ−ティングした鉄片を外部マグネッ
トを介して破壊するとか、綿棒の硬い材質で出来た棒部
分で突き破り、抗生物質と水のカプセルを破壊して溶液
として培地上に流し込むなどして採取端の菌を抗生物質
及び寒天培地と接触させる。ちなみに、寒天培地の代わ
りに乾燥培地を収容して、収容容器内に種々の形態で収
容された水で常用の寒天培地に復帰せしめることも可能
である。また培地には培養結果を正確に判定できるよう
に、pH指示薬や、菌によって分解されて分解産物が菌の
増殖を示す指標となる化学物質の添加を行っても良い
が、これらは多量に存在すると培養を阻害するものもあ
るので適量で添加されることは当然である。
As the medium, a known medium for the resistant bacterium to be detected or a modified medium thereof can be used. The medium is preferably in a liquid state, and it is desirable to fill and store it in an ampoule or a capsule, but it is not limited to this, and for example, an agar medium stored so as not to come into contact with the antibiotic by a fragile partition wall. However, in this case, the partition that is fragile during the culture is destroyed through an external magnet with an iron piece coated with glass placed on the partition, or it is pierced by the stick part made of a hard material of a cotton swab, The bacteria at the collected end are brought into contact with the antibiotic and the agar medium by, for example, breaking the capsule of the antibiotic and water and pouring the solution onto the medium. By the way, it is also possible to store a dry medium instead of the agar medium and to restore the normal agar medium with water stored in various forms in the container. In addition, a pH indicator or a chemical substance that is decomposed by a bacterium and used as an indicator of the growth of the bacterium may be added to the medium so that the culture result can be accurately determined. Then, since some of them may inhibit the culture, it is natural that they are added in an appropriate amount.

【0012】上述の採取端及び抗生物質に関する種々の
収容形態、並びに培地に関する種々の収容形態の選定、
組合せについては、発明の趣旨を逸脱しない限り数多く
の組合せが許容される。特に、抗生物質及び培地(特に
液体培地)の両者とも、あるいは一方を合成樹脂やガラ
ス製のアンプルやカプセルに収容しこれらを破壊するこ
とにより抗生物質及び培地を一体化させる際には、収容
容器のカプセル又はアンプルの収容部が可撓性を有して
いることは、割り具などにより外部から力を作用させて
これらカプセル又はアンプルを容易に破壊することがで
きるため好ましい。特に物理化学の実験に用いられる各
種の破壊しやすい(ブレ−カブルな)機構を有したアン
プルやカプセルは適用するに好ましい。収容容器はコン
パクトなほど好ましいが、培養に必要な空気が存在し得
る体積が確保し得ることは不可欠である。また収容容器
の形状は全体として円筒形のものが積載上好ましいが、
シャ−レ形の円盤上面に突起が出たような形状なども採
用でき、発明の趣旨を逸脱しない限りあらゆる形態が許
容され、材質も各種の培地や抗生物質に不活性な合成樹
脂、天然ゴム、合成ゴム、各種ガラス、各種金属が全体
的にあるいは部分的に選定使用し得る。
[0012] Selection of various accommodation forms for the above-mentioned collection end and antibiotics, and various accommodation forms for the medium,
Regarding the combination, many combinations are allowed without departing from the spirit of the invention. In particular, when both the antibiotic and the medium (particularly the liquid medium) or one of them is contained in a synthetic resin or glass ampoule or capsule and destroyed to integrate the antibiotic and the medium, a container It is preferable that the capsule or ampoule housing section be flexible, because the capsule or ampoule can be easily broken by applying a force from the outside with a split tool or the like. In particular, ampules and capsules having various breakable mechanisms used in physical chemistry experiments are preferable for application. The more compact the storage container is, the more preferable it is, but it is indispensable to secure a volume in which the air necessary for culture can exist. In addition, the shape of the storage container is preferably cylindrical as a whole in terms of loading,
It is also possible to adopt a shape such as a protrusion on the upper surface of a dish-shaped disc, any form is acceptable without departing from the spirit of the invention, and the material is synthetic resin or natural rubber which is inert to various media and antibiotics. , Synthetic rubber, various types of glass, and various types of metals can be selected in whole or in part.

【0013】更にMRSA検知を想定した本発明による具体
的装置の1例である図1をもとに詳述する。この検知装
置は、上端で開口し、下端で閉止した透明な下部チュー
ブ1と;上端で閉止し、下端が多孔板3によって閉止さ
れ、前記透明な下部チューブ1の開口上端と気密に係合
して、透明な下部チューブ1を封止するキャップを兼ね
ると共に、後述する培養液が封入されたガラスアンプル
4を前記閉止された上端と下端多孔板3との間に収容す
る可撓性合成樹脂からなる上部チューブ2と;一端が前
記多孔板3に保持され、他端が前記透明な下部チューブ
1内に伸びる菌採取用の綿棒6と;前記透明な下部チュ
ーブ1内に入れられた前記耐性菌以外の菌の生育を抑制
する後述の抗生物質を含浸した乾燥ディスクチップ5を
包含してなる。
Further, a detailed description will be given with reference to FIG. 1 which is an example of a concrete apparatus according to the present invention which assumes MRSA detection. This detection device has a transparent lower tube 1 that is open at the upper end and closed at the lower end; closed at the upper end, closed at the lower end by a perforated plate 3, and is hermetically engaged with the open upper end of the transparent lower tube 1. A flexible synthetic resin that also serves as a cap for sealing the transparent lower tube 1 and that houses a glass ampoule 4 in which a culture solution described later is enclosed between the closed upper end and lower end perforated plate 3. An upper tube 2; a cotton swab 6 having one end held by the perforated plate 3 and the other end extending into the transparent lower tube 1; and a resistant bacterium placed in the transparent lower tube 1. It includes a dry disk chip 5 impregnated with the below-mentioned antibiotics that suppresses the growth of bacteria other than the above.

【0014】ここに、培養液は、マンニット食塩培地、
スタフィロコッカスブイヨン等の一般的な液体培地のい
ずれでもよく、指示薬としてフェノールレッドを含有
し、培養液の初期pHは7.4で、赤色を呈している。ま
た、乾燥ディスクチップ5は、耐性をもたないグラム陽
性球菌を抑制するオキサシリン、グラム陰性桿菌を抑制
するアゾトレオナム及びポリミキシンBの抗生物質を含
有する。乾燥ディスクチップ5は、吸着担体として合成
樹脂や天然樹脂の特に繊維の集合体であれば種類を問わ
ないが、セルロースペーパーチップが最適である。
Here, the culture solution is a mannitol salt medium,
It may be any common liquid medium such as Staphylococcus broth, contains phenol red as an indicator, and the initial pH of the culture solution is 7.4, which is red. The dried disc chip 5 also contains oxacillin which suppresses gram-positive cocci, which has no resistance, azothreonam which suppresses gram-negative bacilli, and polymyxin B antibiotics. The dry disk chip 5 may be of any kind as long as it is an aggregate of fibers such as synthetic resin or natural resin as an adsorption carrier, but a cellulose paper chip is most suitable.

【0015】かくして、少なくとも抗生物質と培地とは
接触しない状態で収容されているので、長期保存が可能
な耐性菌の簡易検知装置を提供し得ることとなる。
Thus, since at least the antibiotic and the medium are stored in a state where they do not come into contact with each other, it is possible to provide a simple detection device for resistant bacteria which can be stored for a long period of time.

【0016】[0016]

【作用】本発明の検知装置の使用に当たっては、予め滅
菌又は除菌されている菌採取端を収容容器から取り出
し、手早く被検体と接触させて菌を採取し、迅速に再び
収容容器内に気密に収納し、次いで容器外部から外力を
作用せしめて非接触状態を保持していた菌採取端、抗生
物質及び培地を一体的に混合接触させ、常法により一定
時間一定温度のもとに培養し、培地の濁り、コロニーの
成長、増殖した菌に由来の産生物質に基づく物理化学的
な性状の変化を「培地の変化」として検知するとか、あ
るいはまた予め培地に添加しておいた化合物の増殖した
菌による分解などに基づく培地の物理化学的な性状変化
を「培地の変化」として観測して菌の存在を判定するこ
とを意味する。もちろん、培養後に、収容容器から培地
を取り出して以上の観測をすることも可能ではあるが、
そのまま観測し得ることが好ましく、収容容器の少なく
とも培養状況を観測する部位が透明であることが好まし
い。もしも逆に透明であるために収容されている抗生物
質や培地が光によってその性状を変化させる虞がある場
合には、当該透明部に遮光のための被覆、例えば黒色の
テ−プを巻き着けておくことが好ましく、特に培地の変
化を観測する際に取り外し易いほど好適である。
In the use of the detection device of the present invention, the sterilized or sterilized bacterium sampling end is taken out from the container, the sample is quickly brought into contact with the subject, and the bacterium is quickly hermetically sealed again. Then, an external force is applied from the outside of the container to integrally mix and contact the bacteria collection end, which has kept the non-contact state, the antibiotic and the medium, and culture them at a constant temperature for a certain period of time by a conventional method. , Turbidity of the medium, growth of colonies, changes in physicochemical properties based on the production substances derived from the proliferated bacteria are detected as "changes in the medium", or the proliferation of compounds previously added to the medium It means that the presence of the bacterium is determined by observing the change in the physicochemical properties of the medium due to the decomposition by the bacterium as "change of the medium". Of course, after culturing, it is possible to take out the medium from the container and make the above observations,
It is preferable that the cells can be observed as they are, and it is preferable that at least a portion of the container for observing the culture condition is transparent. On the contrary, if the contained antibiotics or culture medium may change its properties due to light because it is transparent, a light-shielding coating such as a black tape may be wrapped around the transparent part. It is preferable to keep it in advance, and it is preferable that it is easy to remove when observing the change of the medium.

【0017】培地として寒天培地を用いる場合は、寒天
培地の上部にある隔壁を薄く構成し隔壁を綿棒で突き壊
す方法に続いて、抗生物質を含むカプセル、水を含むカ
プセルを外力を作用して破壊して培地上に均一に供給す
る方式が好ましい。
When an agar medium is used as the medium, the partition wall above the agar medium is made thin and the partition wall is crushed with a cotton swab, followed by applying an external force to the capsule containing the antibiotic and the capsule containing water. A method of destroying and uniformly supplying on the medium is preferable.

【0018】以上、外力を作用してカプセル、アンプル
あるいは隔壁を破壊することについて種々説明してきた
が、要するに、収容容器の外部から力を作用させる際、
たとえ収容容器が変形しても培養には差し支えないもの
である限り、あるいはまた培養系と外部とが遮断されて
いる限り、換言すれば、収容容器内が外気によって汚染
されることなく、菌と培地と抗生物質とが培養系を形成
できる限り如何なる力の作用も可能であり、こみや軽い
衝撃などあらゆる力の作用をも採用し得る。
Although various explanations have been given on the destruction of the capsule, the ampoule or the partition wall by applying an external force, in short, when applying a force from the outside of the container,
Even if the container is deformed, it does not interfere with culturing, or as long as the culture system is isolated from the outside, in other words, the inside of the container is not contaminated by outside air, and As long as the culture medium and the antibiotic can form a culture system, any action of force can be applied, and any action of force such as dent or light impact can be adopted.

【0019】再度、図1を参照しながら、具体例をMRSA
検知方法について記述する。本発明の「検知装置を使用
する」に当たっては、上部チューブ2を下部チューブ1
からはずし、上部チューブ2を持って綿棒6の先で患者
の鼻腔粘膜、咽頭、又は被検査対象の区域の床、壁、又
は区域内にある家具等の表面を擦る。ついで、検体を採
取した上部チューブ2を元のように下部チューブ1に差
し込み、係合させて気密に封止する。上部チューブ2内
に保持してある培養液が封入されたガラスアンプル4を
外部から例えば市販の割り具を用いて割り、封入された
培養液を多孔板3を通って、綿棒6に沿って下部チュー
ブ1内に落下させ、綿棒の先が培養液内に浸るようにす
る。この際、割れたガラスは多孔板3の上に残り、培養
後の観察に支障を来すことはない。下部チューブ1内に
入った培養液は前述の抗生物質を含浸した乾燥ディスク
チップ5と接触し、乾燥ディスクチップ5に保持された
抗生物質が培養液に溶解する。ついで、下部チューブ1
に上部チュ−ブ2を係合した状態で35℃下に24〜48時間
培養する。培養後、MRSAが存在すると、これらは培養液
中のマンニットを分解するため培養液のpHが酸性とな
り、指示薬フェノ−ルレッドの色調が赤色から黄色に変
色する。従って、判定に当たっては、培養液の黄変によ
って耐性菌の存在が検知できる。
Again referring to FIG. 1, a concrete example of MRSA
Describe the detection method. In "using the detection device" of the present invention, the upper tube 2 is replaced with the lower tube 1.
Then, the upper tube 2 is held and the tip of the swab 6 is rubbed on the nasal mucosa of the patient, the pharynx, or the floor, wall, or the surface of furniture or the like in the area to be inspected. Then, the upper tube 2 from which the sample has been collected is inserted into the lower tube 1 as before, and is engaged and hermetically sealed. The glass ampoule 4 containing the culture solution held in the upper tube 2 is split from the outside using, for example, a commercially available splitting tool, and the enclosed culture solution passes through the perforated plate 3 and moves downward along the cotton swab 6. The tip of the cotton swab is dropped in the tube 1 so that the tip of the cotton swab is immersed in the culture solution. At this time, the broken glass remains on the porous plate 3 and does not hinder the observation after the culture. The culture solution contained in the lower tube 1 comes into contact with the above-mentioned dried disk tip 5 impregnated with the antibiotic, and the antibiotic held by the dried disk tip 5 is dissolved in the culture solution. Then, the lower tube 1
Incubate at 35 ° C. for 24 to 48 hours with the upper tube 2 engaged with. After culturing, when MRSA is present, these decompose mannitol in the culture broth, so that the pH of the culture broth becomes acidic, and the color of the indicator phenol red changes from red to yellow. Therefore, in the determination, the presence of resistant bacteria can be detected by the yellowing of the culture solution.

【0020】存在が検知された菌がMRSAであるか他の耐
性菌であるかについての判定に当たっては、陽性反応を
示した試料について、その培養液の一部をとり、常法ど
おりこれに4−メチルウンベリフェリルリン酸を添加
し、さらに1〜2時間培養した後、MRSAが産生するフォ
スファターゼにより生じた4−メチルウンベリフェロン
の蛍光を波長365nmで検知することにより確認し得る。
併せて、陽性反応を示した試料の他の一部を、やはり常
法どおりウサギプラズマを含有する溶液に添加し、培養
した後、MRSAが産生するコアグラーゼによって生ずるゲ
ル化反応を確認して、多剤耐性菌がMRSAであると判定で
きる。
In determining whether the bacterium whose presence was detected was MRSA or another resistant bacterium, a portion of the culture broth of a sample showing a positive reaction was taken, and 4 -Methylumbelliferyl phosphate is added, and after further culturing for 1 to 2 hours, it can be confirmed by detecting the fluorescence of 4-methylumbelliferone produced by MRSA-produced phosphatase at a wavelength of 365 nm.
At the same time, another part of the sample showing a positive reaction was added to a solution containing rabbit plasma in the same manner as usual, and after culturing, the gelling reaction caused by the coagulase produced by MRSA was confirmed and It can be determined that the drug-resistant bacterium is MRSA.

【0021】この場合、4−メチルウンベリフェリルリ
ン酸についても、上述の抗生物質と同様に、ディスクチ
ップに含浸、凍結乾燥し、一方ウサギプラズマについて
は、ゼラチン水溶液に溶解後、円柱状に成形し、凍結乾
燥してチップとすることにより長期保存性が確保され
る。
In this case, the 4-methylumbelliferyl phosphate was impregnated into the disk chip and freeze-dried in the same manner as the above-mentioned antibiotics, while the rabbit plasma was dissolved in an aqueous gelatin solution and molded into a columnar shape. Then, by freeze-drying it into chips, long-term storability is secured.

【0022】以下に実施例を挙げて、本発明の具体的使
用例を記述するが、発明を限定するものではない。
Hereinafter, specific examples of use of the present invention will be described with reference to examples, but the present invention is not limited thereto.

【0023】[0023]

【実施例1】トリプトン 1.0(w/v)%(以下単に%で
表示)、ラクトース 0.20%、イーストエクストラクト
0.25%、D−マンニット 1.0%、塩化リチウム 0.50
%、塩化ナトリウム 0.40%、フェノールレッド 0.17%
及び精製水からなる液体培地1.5mlをガラスアンプルに
封入し、121℃、120分間で滅菌処理を行った。抗生物質
については、培養液濃度でオキサシリン(6μg/m
l)、アズトレオナム(5μg/ml)及びポリミキシン
B(10μg/ml)となるようにディスクチップに含浸さ
せ、凍結乾燥させた。ガラスアンプル及び乾燥ディスク
チップを収容した図1の装置を用いて下記の試験を行っ
た。
[Example 1] Tryptone 1.0 (w / v)% (hereinafter simply expressed as%), lactose 0.20%, yeast extract
0.25%, D-mannite 1.0%, lithium chloride 0.50
%, Sodium chloride 0.40%, phenol red 0.17%
1.5 ml of liquid medium consisting of purified water and purified water was sealed in a glass ampoule and sterilized at 121 ° C. for 120 minutes. For antibiotics, oxacillin (6 μg / m
l), aztreonam (5 μg / ml) and polymyxin B (10 μg / ml) were impregnated into the disk chips and freeze-dried. The following tests were conducted using the apparatus of Figure 1 containing a glass ampoule and a dry disc chip.

【0024】生検検体は、A病院に入院するMRSA罹患患
者20名、及び医療従事者20名から採取したものである。
対照としての陽性標準検体(n=10)に関しては、検定
済みの多剤耐性標準検体1としてMRSAを及び陽性標準検
体2として多剤耐性CNSをそれぞれ104/チューブで使用
した。陰性標準検体としてはスタフィロコッカス・エピ
デルミディス(Staphylococcus epidermidis)を104 /
チューブで使用した。各被検者の咽頭、鼻腔、手指から
綿棒にて検体を採取し、綿棒を樹脂(ポリエチレン:以
下単に樹脂と記載)製の下部チューブ内に入れ、キャッ
プを気密に係合した後、樹脂製の上部チューブ内の液体
培地封入ガラスアンプルを上部チューブの外から割り具
によって割り、液体培地を下部樹脂製チューブに流入さ
せた。培養温度35℃で24〜48時間培養後、培地変化の判
定を行った。判定は培地の色調変化を観察して行い、赤
色のままのものを陰性、黄色に変色したものを陽性と判
定した。
The biopsy specimens were collected from 20 MRSA-affected patients and 20 healthcare workers admitted to Hospital A.
Regarding the positive standard sample (n = 10) as a control, MRSA was used as the tested multidrug resistant standard sample 1 and multidrug resistant CNS was used as the positive standard sample 2 in 104 / tube, respectively. As a negative standard sample, Staphylococcus epidermidis 104 /
Used in tubes. Specimens are collected from each subject's pharynx, nasal cavity, and fingers with a cotton swab, and the cotton swab is placed in a lower tube made of resin (polyethylene: simply referred to as resin below), and the cap is hermetically engaged, and then made of resin. The glass ampoule enclosing the liquid medium in the upper tube of No. 1 was split from outside the upper tube with a splitting tool, and the liquid medium was allowed to flow into the lower resin tube. After culturing at a culturing temperature of 35 ° C. for 24 to 48 hours, the medium change was judged. The judgment was made by observing the change in the color tone of the medium, and those that remained red were judged to be negative, and those that changed to yellow were judged to be positive.

【0025】なお、培地が黄変した陽性検体につき、さ
らにフォスファターゼ及びコアグラーゼ産生の有無を4
−メチルウンベリフェロンの蛍光及びウサギプラズマの
ゲル化で検討した。
It should be noted that the presence of production of phosphatase and coagulase in the positive sample in which the medium turned yellow was further checked for 4
-Methylumbelliferone was investigated by fluorescence and rabbit plasma gelation.

【0026】多剤耐性菌の存在に関する培地の変色によ
る試験結果を表1に、陽性検体について行ったフォスフ
ァターゼ及びコアグラーゼテストの結果を表2にそれぞ
れ示す。
Table 1 shows the test results by the discoloration of the medium for the presence of multidrug-resistant bacteria, and Table 2 shows the results of the phosphatase and coagulase tests conducted on the positive samples.

【0027】[0027]

【表1】 試験結果 検 体 の 種 類 対象部位 MRSA罹患患者 医療従事者 (培地の色調変化) (培地の色調変化) 咽 頭 20/20 3/20 鼻 腔 20/20 2/20 手 指 12/20 4/20 陽性標準検体1 10/10 陽性標準検体2 10/10 陰性標準検体 0/10[Table 1] Test results Species Target site MRSA sufferers Medical staff (Change in color tone of medium) ( Change in color tone of medium ) Pharynx 20/20 3/20 Nasal cavity 20/20 2/20 Fingers 12/20 4/20 Positive standard sample 1 10/10 Positive standard sample 2 10/10 Negative standard sample 0/10

【0028】[0028]

【表2】 試験結果 検 体 の 種 類 対象部位 M R S A 罹 患 患 者 医 療 従 事 者 フォスファターセ゛試験 コアク゛ラーセ゛試験 フォスファターセ゛試験 コアク゛ラーセ゛ 試験 咽 頭 20/20 20/20 2/20 2/20 鼻 腔 20/20 20/20 1/20 1/20 手 指 8/20 8/20 2/20 2/20 陽性標準検体1 10/10 10/10 陽性標準検体2 10/10 10/10 陰性標準検体 0/10 0/10[Table 2] Test results Species Target site MRSA Affected patient Medical patient Fosufatase Bu test Koaku Bu Bu Rase test Fosufatase Bu test Koaku Bu Bu Rase test throat head 20/20 20/20 2/20 2/20 nose cavity 20/20 20/20 1/20 1/20 fingers 8/20 8/20 2/20 2/20 Positive standard sample 1 10/10 10/10 Positive standard sample 2 10/10 10/10 Negative standard sample 0/10 0/10

【0029】上記表1及び表2において、試験結果を以
下のように表示している。 液体培地の色調変化:培地の色調が赤色から黄色に変化
した例数/総検体数 フォスファターゼ試験:青色に蛍光を発した陽性例数/
総検体数 コアグラーゼ試験:ウサギプラズマ溶液がゲル化した陽
性例数/総検体数
In Tables 1 and 2 above, the test results are displayed as follows. Change in color tone of liquid medium: Number of cases where color tone of medium changed from red to yellow / total number of samples Phosphatase test: Number of positive cases that fluoresce in blue /
Total number of samples Coagulase test: Number of positive cases of gelation of rabbit plasma solution / Total number of samples

【0030】表1から明らかなように、検知結果はMRSA
罹患患者の咽頭、鼻腔においては全例陽性であった。手
指は60%の検知率であった。医療従事者の咽頭、鼻腔、
手指においては、それぞれ15%、10%、20%の検知率で
あった。
As is clear from Table 1, the detection result is MRSA.
All cases were positive in the pharynx and nasal cavity of affected patients. The finger had a detection rate of 60%. The pharynx, nasal cavity,
In the fingers, the detection rates were 15%, 10%, and 20%, respectively.

【0031】さらに液体培地の色調が赤色から黄色に変
化した陽性例に対して行ったフォスファターゼ試験及び
コアグラーゼ試験では、表2から明らかなように、MRSA
罹患患者の咽頭、鼻腔においては全例陽性であった。手
指は60%の検知率であった。医療従事者の咽頭、鼻腔、
手指においては、それぞれ10%、5%、10%の検知率で
あった。このことは、医療従事者における本発明の簡易
検知装置での陽性結果とフォスファターゼ試験あるいは
コアグラーゼ試験での陽性結果との差は、MRSA以外に、
同じ多剤耐性を有するCNSも検知されていたことを意味
する。
Furthermore, in the phosphatase test and the coagulase test performed on the positive cases in which the color tone of the liquid medium changed from red to yellow, it is clear from Table 2 that MRSA
All cases were positive in the pharynx and nasal cavity of affected patients. The finger had a detection rate of 60%. The pharynx, nasal cavity,
In the fingers, the detection rates were 10%, 5%, and 10%, respectively. This means that the difference between the positive result in the simple detection device of the present invention in the medical staff and the positive result in the phosphatase test or the coagulase test, other than MRSA,
This means that CNS with the same multidrug resistance was also detected.

【0032】[0032]

【実施例2】実施例1で調製した本発明の簡易検知装置
を用い、従来法との保存安定性について比較検討した。
従来法では市販のMRSAスクリーニング用寒天平板培地
(フードスタンプ「ニッスイ」MSO寒天;日水製薬株式
会社)を用い、寒天平板培地を冷蔵で3ヶ月間保存した
後使用した。一方、本発明の簡易検知装置は15℃で1年
間及び40℃で2ヶ月間保存した後使用した。試験は各検
定菌毎3回行った。
[Example 2] Using the simple detection device of the present invention prepared in Example 1, the storage stability of the conventional method was compared and examined.
In the conventional method, a commercially available agar plate medium for MRSA screening (Food Stamp "Nissui" MSO agar; Nissui Pharmaceutical Co., Ltd.) was used, and the agar plate medium was stored after refrigeration for 3 months before use. On the other hand, the simple detection device of the present invention was used after being stored at 15 ° C for 1 year and at 40 ° C for 2 months. The test was performed 3 times for each test strain.

【0033】検定に当たり、グラム陽性菌としてMRSA、
CNS、スタフィロコッカス・エピデルミディス、スタフ
ィロコッカス・アウレウス、エンテロコッカス・フェカ
リス(Enterococus faecalis)、グラム陰性菌としてエ
シェリキア・コリ(Escherichia coli)、クレブシエラ
・ニューモニエ(Klebsiella pneumoniae)、セラチア
・マルセッセンス(Serratia marcescens)、プロテウ
ス・ブルガリス(Proteus vulgaris)、シュードモナス
・アエルギノーザ(Pseudomonas aeruginosa)を104/
チューブで使用して試験を行った。
In the assay, MRSA as Gram-positive bacteria,
CNS, Staphylococcus epidermidis, Staphylococcus aureus, Enterococus faecalis, Gram-negative bacteria Escherichia coli, Klebsiella pneumoniae, Serratia marcesces, Serassia marcesces 104 / Proteus vulgaris, Pseudomonas aeruginosa
Tested using in tubes.

【0034】得られた結果を表3に示す。The results obtained are shown in Table 3.

【0035】[0035]

【表3】 試験結果 検 定 菌 本発明の検知装置 市販MRSAスクリーニンク゛用寒天培地 MRSA 3/3 3/3 3/3 3/3 CNS 3/3 3/3 3/3 3/3 S.エヒ゜テ゛ルミテ゛ィス 0/3 0/3 1/3 3/3 S.アウレウス 0/3 0/3 0/3 3/3 E.フェカリス 0/3 0/3 1/3 3/3 E.コリ 0/3 0/3 0/3 2/3 K.ニューモニエ 0/3 0/3 0/3 3/3 S.マルセッセンス 0/3 0/3 0/3 3/3 P.フ゛ルカ゛リス 0/3 0/3 0/3 2/3 P.アエルキ゛ノーサ゛ 0/3 0/3 0/3 3/3 A:15℃、1年間保存 B:40℃、2カ月間保存 C:
冷蔵下、1週間保存D:冷蔵下、3カ月保存
[Table 3] Test results Tested bacteria Detection device of the present invention Commercial agar medium for MRSA screening A B C D MRSA 3/3 3/3 3/3 3/3 CNS 3/3 3/3 3/3 3/3 S. Extended duty 0/3 0/3 1/3 3/3 S.E. Aureus 0/3 0/3 0/3 3/3 E. Faecalis 0/3 0/3 1/3 3/3 E. Kori 0/3 0/3 0/3 2/3 K. Pneumonier 0/3 0/3 0/3 3/3 S. Marcescence 0/3 0/3 0/3 3/3 P. Burgeris 0/3 0/3 0/3 2/3 P.I. Aeruginosa 0/3 0/3 0/3 3/3 A: 15 ° C, 1 year storage B: 40 ° C, 2 months storage C:
Store under refrigeration for 1 week D: Store under refrigeration for 3 months

【0036】以上の結果より、本発明の簡易検知装置に
おいては、15℃で1年間及び40℃で2ヶ月間の保存品の
両者供、MRSA及びCNSの全例に液体培地の色調の黄変
(陽性)が認められ、その他の菌においては総て陰性を
示した。従来法である市販の寒天培地は、冷蔵で3ヶ月
間保存したものでは、MRSA及びCNS以外の菌も同様に発
育し、正しくMRSA及びCNSを検知することが出来なかっ
た。このことは、寒天培地中に含有する抗生物質の分解
が生じ、MRSA及びCNS以外の菌の増殖抑制が弱まった結
果と考えられる。このように市販の寒天培地において
は、保存安定性に問題があった。本発明の簡易検知装置
においては、抗生物質が凍結乾燥されたディスクチップ
とガラスアンプルに封入された液体培地とが培養直前ま
で簡易検知装置内に分離され接触していないため、抗生
物質がその活性を安定に保ち、長期保存が達成し得る。
From the above results, in the simple detection device of the present invention, both the stored product for 1 year at 15 ° C. and the storage for 2 months at 40 ° C., and the yellowing of the color tone of the liquid medium was observed in all MRSA and CNS cases. (Positive) was observed, and all other bacteria were negative. When the commercially available agar medium, which is a conventional method, was stored in a refrigerator for 3 months, bacteria other than MRSA and CNS also grew and MRSA and CNS could not be detected correctly. It is considered that this is because the antibiotic contained in the agar medium was decomposed and the growth inhibition of bacteria other than MRSA and CNS was weakened. As described above, the commercially available agar medium has a problem in storage stability. In the simple detection device of the present invention, since the disk chip in which the antibiotic is freeze-dried and the liquid medium enclosed in the glass ampoule are separated and not in contact with each other in the simple detection device until just before the culture, the antibiotic is activated. Stable and long-term storage can be achieved.

【0037】[0037]

【発明の効果】本発明による簡易検知装置は、菌採取
端、培地及び抗生物質を収容容器内に被接触的にかつ一
括収容されているため、長期保存が可能な耐性菌検知作
業に好適な装置を提供し、その結果として菌採取から培
養までの操作及び培養後の判定操作が非常に短時間にな
し得るものであり、熟練及び専門知識を要することな
く、確実に、多数の検体を処理できる方法を提供するも
のである。従って、多数の採取検体の耐性菌感染の早期
発見が可能となり、問題になっているMRSAなどの院内感
染防止対策の一助とすることができる。また、抗生物質
に限らず保存不安定な培地を分割収容して安定性を付与
した培養装置に応用、適用できる。
EFFECTS OF THE INVENTION The simple detection device according to the present invention is suitable for detecting resistant bacteria capable of long-term storage because the bacteria collection end, the culture medium and the antibiotics are stored in a container in a contact manner and collectively. A device is provided, and as a result, the operations from bacterial collection to culture and the determination operation after culture can be performed in a very short time, and a large number of samples can be processed reliably without requiring skill and expertise. It provides a way to do it. Therefore, it is possible to detect a resistant bacterial infection in a large number of collected samples at an early stage, and it can be useful for preventing nosocomial infections such as MRSA, which is a problem. In addition, it can be applied and applied to a culture device in which not only antibiotics but also storage-unstable media are divided and stored to provide stability.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明による多剤耐性菌の簡易検知装置の概略
図である。
FIG. 1 is a schematic view of a simple detection device for multidrug-resistant bacteria according to the present invention.

【符号の説明】[Explanation of symbols]

1 下部チューブ 2 上部チューブ 3 多孔板 4 ガラスアンプル 5 乾燥ディスクチップ 6 綿棒 1 Lower tube 2 Upper tube 3 Perforated plate 4 Glass ampoule 5 Dry disc tip 6 Cotton swab

───────────────────────────────────────────────────── フロントページの続き (72)発明者 三和 亜通志 千葉県千葉市若葉区御成台1−6−4 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Atsushi Sanwa 1-6-4 Onaridai, Wakaba-ku, Chiba-shi, Chiba

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】菌を培地で培養して培地の変化を観察する
ことにより菌を検知する装置において、外力の作用によ
り互いに一体的に接触する菌採取端、抗生物質及び培地
を包含してなり、少なくとも前記抗生物質と培地とが非
接触的に収容容器に配置されていることを特徴とする選
択的耐性菌検知装置。
1. An apparatus for detecting a bacterium by culturing the bacterium in a medium and observing a change in the medium, which comprises a bacterium sampling end, an antibiotic and a medium which are integrally brought into contact with each other by the action of an external force. At least the antibiotic and the medium are arranged in a non-contact manner in a container, and the selective resistant bacteria detecting device is characterized.
JP12574094A 1994-05-16 1994-05-16 Device for simply detecting resistant microorganism Withdrawn JPH07308184A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12574094A JPH07308184A (en) 1994-05-16 1994-05-16 Device for simply detecting resistant microorganism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12574094A JPH07308184A (en) 1994-05-16 1994-05-16 Device for simply detecting resistant microorganism

Publications (1)

Publication Number Publication Date
JPH07308184A true JPH07308184A (en) 1995-11-28

Family

ID=14917624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12574094A Withdrawn JPH07308184A (en) 1994-05-16 1994-05-16 Device for simply detecting resistant microorganism

Country Status (1)

Country Link
JP (1) JPH07308184A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020107A1 (en) * 1996-11-07 1998-05-14 Srl, Inc. Bacterium detector
JP2002034553A (en) * 2000-07-24 2002-02-05 Eiken Chem Co Ltd Medium for screening mrsa
US6919200B2 (en) * 1998-11-23 2005-07-19 The United States Of America As Represented By The Secretary Of The Army Purification method and apparatus
JP2006223168A (en) * 2005-02-17 2006-08-31 Nikken Seibutsu Igaku Kenkyusho:Kk Examination tool
US7232681B2 (en) * 2003-04-24 2007-06-19 O'connell David Personal cell sampling kit
JP2012105643A (en) * 2010-10-28 2012-06-07 Eiken Chemical Co Ltd Disk test specimen for detecting drug-resistant bacterium
CN109439532A (en) * 2018-12-26 2019-03-08 武汉慧康利兹食品有限公司 Detection device for essence microorganism

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020107A1 (en) * 1996-11-07 1998-05-14 Srl, Inc. Bacterium detector
US6197574B1 (en) 1996-11-07 2001-03-06 Srl, Inc. Bacterium detector
AU731465B2 (en) * 1996-11-07 2001-03-29 Fujirebio Inc. Apparatus for detecting microorganism
US6919200B2 (en) * 1998-11-23 2005-07-19 The United States Of America As Represented By The Secretary Of The Army Purification method and apparatus
JP2002034553A (en) * 2000-07-24 2002-02-05 Eiken Chem Co Ltd Medium for screening mrsa
JP4583559B2 (en) * 2000-07-24 2010-11-17 栄研化学株式会社 Medium for MRSA screening
US7232681B2 (en) * 2003-04-24 2007-06-19 O'connell David Personal cell sampling kit
JP2006223168A (en) * 2005-02-17 2006-08-31 Nikken Seibutsu Igaku Kenkyusho:Kk Examination tool
JP2012105643A (en) * 2010-10-28 2012-06-07 Eiken Chemical Co Ltd Disk test specimen for detecting drug-resistant bacterium
CN109439532A (en) * 2018-12-26 2019-03-08 武汉慧康利兹食品有限公司 Detection device for essence microorganism

Similar Documents

Publication Publication Date Title
KR100453094B1 (en) Bacteria detection mechanism
US5163441A (en) Polyurethane biological sample collection and transport device and its use
Lowbury Contamination of cetrimide and other fluids with Pseudomonas pyocyanea
US5091316A (en) Biological sample collection and transport device
MacLowry et al. Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing
JP2014502503A (en) Sterilization indicator and method comprising a porous carrier
JP6759328B2 (en) Liquids, especially body fluids treatment equipment and methods
JP4047391B2 (en) Micropathological patient replica based on whole blood without impurities
US3728228A (en) Device for indication of bacterial sensitivity to antibiotics
JPH11510051A (en) Multi-zone sterilization indicator
JPH07308184A (en) Device for simply detecting resistant microorganism
JP3431812B2 (en) Bacteria detection instrument
SE414410B (en) AGENTS FOR PAVISANING NEISSERIA GONORRHEAE THROUGH ITS OXIDA ACTIVITY
Marquette et al. Bronchoscopic protected catheter brush for the diagnosis of pulmonary infections
EP0346732B1 (en) Biological sample collection and transport device
WO2009151346A1 (en) A method for determining bacterial antibiotic resistance or bacterial susceptibility, a diagnostic kit for the detection of the antibiotic resistance and use of such diagnostic kit
CA1264274A (en) Detection of microbial pathogens
US20070122872A1 (en) Method for storage of clinical samples prior to culture
Hall Mercury resistance of Staphylococcus aureus
Stroy et al. Specific assay of aminoglycosidic-or polymyxin-type antibiotics present in human sera in combination with cephalosporins
US20210060550A1 (en) Devices and methods for detection of microorganisms
RU2184781C2 (en) Method of diagnosing chelicobacteriosis from estimation of urease activity of biological material and device realization thereof
Liberman et al. Rapid disk test for determining clindamycin serum levels
Cronberg et al. Drug sensitivity of bacteria isolated by blood culture
US20210348115A1 (en) Biological transport systems and methods

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20010731